Why Accenture is investing in the Seattle startup Iridius to unblock AI in regulated industries
Brian Buntz
Companies from Palantir to Salesforce to Veeva are racing to speed up regulatory workflows with AI agents, as is a wave of startups targeting everything from clinical document generation to pharmacovigilance case processing. Meanwhile, many large pharmas are pursuing a build-and-compose strategy of their own, stitching AI into existing regulatory systems, validated workflows and company-specific… The post Why Accenture is investing in the Seattle startup Iridius to unblock AI in regulated indust